North Media A/S
22.2.2021 17:20:49 CET | Globenewswire | Press release
Company announcement No 07-2021
22 February 2021
Pursuant to article 19 of regulation (EU) no. 596/2014 of the European Parliament and of the Council on market abuse (as amended) persons discharging managerial responsibilities in North Media A/S and/or persons closely related with them must notify the Danish Financial Supervisory Authority and notify North Media A/S of transactions related to shares and/or linked financial instruments in North Media A/S.
North Media A/S hereby makes public pursuant to article 19 of regulation (EU) no. 596/2014 of the European Parliament and of the Council on market abuse (as amended) the following information received from persons discharging managerial responsibilities in North Media A/S and/or persons closely related with them (see attached).
The transaction pertains to exercise of stock options:
| Name | Holdings before transaction, no. of shares | Transaction, no. of shares | Holdings after transaction, no. of shares |
| Kåre Stausø Wigh (acquisition) | 80,000 | 20,000 | 100,000 |
For further information
Kåre Wigh, Group Executive Director & CFO, mobile +45 25 65 21 45
This document is an unofficial translation of the Danish original. In the event of any inconsistencies, the Danish version shall apply.
Attachment
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
King Faisal Specialist Hospital & Research Centre13.3.2026 22:15:53 CET | Press release
KFSH Leads Globally in Paired Kidney Transplants Performed at a Single Center in 2025
SCOR13.3.2026 18:59:39 CET | Press release
SCOR SE announces the availability of its 2025 Universal Registration Document
Novartis Pharma AG13.3.2026 18:35:19 CET | Press release
Novartis Cosentyx® receives FDA approval for pediatric patients aged 12+ with moderate to severe hidradenitis suppurativa
Luotea Oyj13.3.2026 18:30:00 CET | Press release
The Board of Directors of Luotea Oyj decided on updates to the company's share-based incentive plan for 2023-2027 and on the launch of a new share-based incentive plan for the years 2026-2030
Ilkka Oyj13.3.2026 18:00:00 CET | Press release
Ilkka Oyj: Acquisition of own shares on 13 March 2026
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
